Natixis Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,042
| Closed | -$472K | – | 1622 |
|
|
2024
Q3 | $472K | Sell |
10,042
-864
| -8% | -$40.6K | ﹤0.01% | 1465 |
|
|
2024
Q2 | $589K | Buy |
10,906
+400
| +4% | +$21.6K | ﹤0.01% | 1397 |
|
|
2024
Q1 | $716K | Buy |
10,506
+365
| +4% | +$24.9K | ﹤0.01% | 1302 |
|
|
2023
Q4 | $634K | Sell |
10,141
-1,566
| -13% | -$97.9K | ﹤0.01% | 1338 |
|
|
2023
Q3 | $531K | Sell |
11,707
-308
| -3% | -$14K | ﹤0.01% | 1347 |
|
|
2023
Q2 | $675K | Sell |
12,015
-434
| -3% | -$24.4K | ﹤0.01% | 1262 |
|
|
2023
Q1 | $563K | Sell |
12,449
-306
| -2% | -$13.8K | ﹤0.01% | 1287 |
|
|
2022
Q4 | $519K | Sell |
12,755
-2,702
| -17% | -$110K | ﹤0.01% | 1289 |
|
|
2022
Q3 | $1.01M | Sell |
15,457
-1,676
| -10% | -$110K | ﹤0.01% | 1106 |
|
|
2022
Q2 | $1.04M | Sell |
17,133
-402
| -2% | -$24.4K | ﹤0.01% | 1114 |
|
|
2022
Q1 | $1.1M | Buy |
17,535
+83
| +0.5% | +$5.21K | ﹤0.01% | 1105 |
|
|
2021
Q4 | $1.32M | Sell |
17,452
-1,676
| -9% | -$127K | 0.01% | 1065 |
|
|
2021
Q3 | $2.14M | Buy |
19,128
+9,104
| +91% | +$1.02M | 0.01% | 894 |
|
|
2021
Q2 | $1.62M | Buy |
+10,024
| New | +$1.62M | 0.01% | 981 |
|